All Stories

  1. Metabolite-related antidepressant action of diterpene ginkgolides in the prefrontal cortex
  2. Decreased serum proNGF concentration in patients with Parkinson’s disease
  3. Recombinant tissue plasminogen activator induces long-term anxiety-like behaviors via the ERK1/2-GAD1-GABA cascade in the hippocampus of a rat model
  4. Venlafaxine exerts antidepressant effects possibly by activating MAPK–ERK1/2 and P13K–AKT pathways in the hippocampus
  5. Cerebrovascular risk factors for patients with cerebral watershed infarction
  6. Treatment of insomnia with tricyclic antidepressants: a meta-analysis of polysomnographic randomized controlled trials
  7. Complementary and Alternative Therapies for Restless Leg Syndrome: An Evidence-Based Systematic Review
  8. Tricyclic antidepressants for preventing migraine in adults
  9. Efficacy and feasibility of antidepressants for the prevention of migraine in adults: a meta-analysis
  10. Serum Butyrylcholinesterase Activity: A Biomarker for Parkinson’s Disease and Related Dementia
  11. GC–MS-based metabolomic study on the antidepressant-like effects of diterpene ginkgolides in mouse hippocampus
  12. Efficacy and feasibility of antidepressant treatment in patients with post-stroke depression
  13. Recombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-Analysis
  14. Fibulin-5: a novel biomarker for evaluating severity and predicting prognosis in patients with acute intracerebral haemorrhage
  15. Blend Sign on Computed Tomography
  16. Intraventricular Hemorrhage and Early Hematoma Expansion in Patients with Intracerebral Hemorrhage
  17. A Novel Urinary Metabolite Signature for Diagnosing Major Depressive Disorder